Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder Browse All Topics Envelope icon E-mail Updates Teal square Text size:  a A A

To watch a video about this final recommendation and learn more, click here.

Autism Spectrum Disorder in Young Children: Screening

Release Date: February 2016

Recommendation Summary

PopulationRecommendationGrade
(What's This?)
Children aged 18 to 30 months

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

See the Clinical Considerations for suggestions for practice regarding the I statement.

To read the recommendation statement in JAMA, click here.

Related Information for Health Professionals

There is no related information for health professionals.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: March 2016

Internet Citation: Final Update Summary: Autism Spectrum Disorder in Young Children: Screening. U.S. Preventive Services Task Force. March 2016.
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/autism-spectrum-disorder-in-young-children-screening

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857